Literature DB >> 29097623

DnaJ Heat Shock Protein Family B Member 9 Is a Novel Biomarker for Fibrillary GN.

Surendra Dasari1, Mariam P Alexander2, Julie A Vrana2, Jason D Theis2, John R Mills2, Vivian Negron2, Sanjeev Sethi2, Angela Dispenzieri2,3, W Edward Highsmith2, Samih H Nasr4, Paul J Kurtin2.   

Abstract

Fibrillary GN (FGN) is a rare primary glomerular disease. Histologic and histochemical features of FGN overlap with those of other glomerular diseases, and no unique histologic biomarkers for diagnosing FGN have been identified. We analyzed the proteomic content of glomeruli in patient biopsy specimens and detected DnaJ heat shock protein family (Hsp40) member B9 (DNAJB9) as the fourth most abundant protein in FGN glomeruli. Compared with amyloidosis glomeruli, FGN glomeruli exhibited a >6-fold overexpression of DNAJB9 protein. Sanger sequencing and protein sequence coverage maps showed that the DNAJB9 protein deposited in FGN glomeruli did not have any major sequence or structural alterations. Notably, we detected DNAJB9 in all patients with FGN but not in healthy glomeruli or in 19 types of non-FGN glomerular diseases. We also observed the codeposition of DNAJB9 and Ig-γ Overall, these findings indicate that DNAJB9 is an FGN marker with 100% sensitivity and 100% specificity. The magnitude and specificity of DNAJB9 overabundance in FGN also suggests that this protein has a role in FGN pathogenesis. With this evidence, we propose that DNAJB9 is a strong biomarker for rapid diagnosis of FGN in renal biopsy specimens.
Copyright © 2018 by the American Society of Nephrology.

Entities:  

Keywords:  DNAJB9; biomarker; fibrillary GN; immunofluorescence; proteomics; renal

Mesh:

Substances:

Year:  2017        PMID: 29097623      PMCID: PMC5748911          DOI: 10.1681/ASN.2017030306

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  20 in total

1.  Shotgun-proteomics-based clinical testing for diagnosis and classification of amyloidosis.

Authors:  Jason D Theis; Surendra Dasari; Julie A Vrana; Paul J Kurtin; Ahmet Dogan
Journal:  J Mass Spectrom       Date:  2013-10       Impact factor: 1.982

2.  Nomenclature 2014: Amyloid fibril proteins and clinical classification of the amyloidosis.

Authors:  Jean D Sipe; Merrill D Benson; Joel N Buxbaum; Shu-ichi Ikeda; Giampaolo Merlini; Maria J M Saraiva; Per Westermark
Journal:  Amyloid       Date:  2014-09-29       Impact factor: 7.141

3.  Fibrillary glomerulonephritis: a report of 66 cases from a single institution.

Authors:  Samih H Nasr; Anthony M Valeri; Lynn D Cornell; Mary E Fidler; Sanjeev Sethi; Nelson Leung; Fernando C Fervenza
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

4.  Outcome of fibrillary glomerulonephritis.

Authors:  Stefan A Kalbermatter; Claudio Marone; Donatella Casartelli; Martin Hausberg; Giovanni Banfi; Michael Mihatsch; Michael Dickenmann
Journal:  Swiss Med Wkly       Date:  2012-05-02       Impact factor: 2.193

5.  Fibrillary glomerulonephritis in siblings.

Authors:  T M Chan; K W Chan
Journal:  Am J Kidney Dis       Date:  1998-05       Impact factor: 8.860

6.  Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.

Authors:  A Fogo; N Qureshi; R G Horn
Journal:  Am J Kidney Dis       Date:  1993-09       Impact factor: 8.860

7.  Fibrillary and immunotactoid glomerulonephritis: Distinct entities with different clinical and pathologic features.

Authors:  Jordan L Rosenstock; Glen S Markowitz; Anthony M Valeri; Giuseppe Sacchi; Gerald B Appel; Vivette D D'Agati
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

8.  Long-term kidney disease outcomes in fibrillary glomerulonephritis: a case series of 27 patients.

Authors:  Vincent Javaugue; Alexandre Karras; François Glowacki; Brigitte McGregor; Corinne Lacombe; Jean-Michel Goujon; Stéphanie Ragot; Pierre Aucouturier; Guy Touchard; Frank Bridoux
Journal:  Am J Kidney Dis       Date:  2013-06-04       Impact factor: 8.860

9.  Fibrillary glomerulonephritis and immunotactoid glomerulopathy.

Authors:  Charles E Alpers; Jolanta Kowalewska
Journal:  J Am Soc Nephrol       Date:  2007-11-28       Impact factor: 10.121

10.  Comparative shotgun proteomics using spectral count data and quasi-likelihood modeling.

Authors:  Ming Li; William Gray; Haixia Zhang; Christine H Chung; Dean Billheimer; Wendell G Yarbrough; Daniel C Liebler; Yu Shyr; Robbert J C Slebos
Journal:  J Proteome Res       Date:  2010-08-06       Impact factor: 4.466

View more
  30 in total

1.  Clinicopathological characteristics and outcome of patients with fibrillary glomerulonephritis: DNAJB9 is a valuable histologic marker.

Authors:  Shaoshan Liang; Dacheng Chen; Dandan Liang; Feng Xu; Mingchao Zhang; Fan Yang; Xiaodong Zhu; Ping Li; Caihong Zeng
Journal:  J Nephrol       Date:  2020-06-18       Impact factor: 3.902

Review 2.  The Complexity and Heterogeneity of Monoclonal Immunoglobulin-Associated Renal Diseases.

Authors:  Sanjeev Sethi; S Vincent Rajkumar; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2018-04-27       Impact factor: 10.121

Review 3.  CFHR Gene Variations Provide Insights in the Pathogenesis of the Kidney Diseases Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

Authors:  Peter F Zipfel; Thorsten Wiech; Emma D Stea; Christine Skerka
Journal:  J Am Soc Nephrol       Date:  2020-01-24       Impact factor: 10.121

Review 4.  The tissue proteome in the multi-omic landscape of kidney disease.

Authors:  Markus M Rinschen; Julio Saez-Rodriguez
Journal:  Nat Rev Nephrol       Date:  2020-10-07       Impact factor: 28.314

5.  Glomerular Disease Pathology in the Era of Proteomics: From Pattern to Pathogenesis.

Authors:  Mark Haas
Journal:  J Am Soc Nephrol       Date:  2017-11-02       Impact factor: 10.121

6.  Protein Mass Spectrometry Made Simple.

Authors:  Jon B Klein; Mark A Knepper
Journal:  J Am Soc Nephrol       Date:  2018-05-03       Impact factor: 10.121

7.  Fibrillary Glomerulonephritis: Clinicopathologic Features and Atypical Cases from a Multi-Institutional Cohort.

Authors:  Nicole K Andeen; Megan L Troxell; Maziar Riazy; Rupali S Avasare; Jessica Lapasia; J Ashley Jefferson; Shreeram Akilesh; Behzad Najafian; Roberto F Nicosia; Charles E Alpers; Kelly D Smith
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-04       Impact factor: 8.237

8.  Complete remission of DnaJ homolog subfamily B member 9-positive fibrillary glomerulonephritis following steroid monotherapy in an elderly Japanese woman.

Authors:  Takahiro Uchida; Shuuhei Komatsu; Takashi Sakai; Aki Kojima; Sachiko Iwama; Kentaro Sugisaki; Takashi Oda
Journal:  CEN Case Rep       Date:  2021-03-03

9.  Filgrastim-induced recurrent macroscopic hematuria in a patient with DNAJB9 positive fibrillary glomerulonephritis.

Authors:  Anne-Laure Faucon; Sophie Cereja; Charlotte Mussini; Jean-Michel Goujon; Valérie Caudwell
Journal:  J Nephrol       Date:  2022-02-24       Impact factor: 3.902

Review 10.  Artificial intelligence and machine learning in nephropathology.

Authors:  Jan U Becker; David Mayerich; Meghana Padmanabhan; Jonathan Barratt; Angela Ernst; Peter Boor; Pietro A Cicalese; Chandra Mohan; Hien V Nguyen; Badrinath Roysam
Journal:  Kidney Int       Date:  2020-04-01       Impact factor: 10.612

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.